UBS Downgrades NUVL to 'Hold' with a $124 Price Target
UBS lowers its rating on NUVL to 'hold' with a $124 target price.
Key Points
- On June 10, 2026, UBS downgraded NUVL to a 'hold' rating with a price target of $124.
- NUVL shares were trading around $123.25 following the analyst actions.
- Other firms like TD Cowen and Barclays also downgraded NUVL to 'hold' on the same day.
On June 10, 2026, UBS downgraded its rating on NUVL to 'hold' and set a price target of $124. This change comes as part of a broader analyst reassessment of the company.
Other Institutional Activity in NUVL
Several institutional investors have made notable moves in NUVL recently. Deerfield Management Company maintained its position with 17,248,450 shares valued at approximately $1.77 billion. FMR LLC trimmed its holdings by 1,577,925 shares, leaving it with 9,274,959 shares worth about $950.2 million. Meanwhile, Paradigm Biocapital Advisors LP added 55,000 shares, bringing its total to 5,324,433 shares valued at $545.5 million. BlackRock, Inc. also increased its stake slightly by 19,524 shares, now holding 4,824,785 shares valued at $494.3 million. JPMorgan Chase & Co significantly boosted its holdings by 883,098 shares, resulting in a total of 3,088,349 shares valued at $298.7 million.
NUVL Stock Snapshot
NUVL shares were trading around $123.25 recently. The stock has seen a series of analyst downgrades, which may impact its short-term trading dynamics. Without specific financial metrics available, other details such as market cap and P/E ratio are not discussed.
Insider Buying and Selling at Nuvalent, Inc.
Recent insider transactions at NUVL include several sales and purchases. On June 9, 2026, Darlene Noci, the Chief Development Officer, sold 20,000 shares at an average price of $122.81 under a planned sale. On the same day, she also bought 20,000 shares at approximately $9.59. On June 8, 2026, President and CEO James Richard Porter sold 30,000 shares at an average price of $88.53 in a planned transaction and bought the same amount at around $18.93.
Analysts Set New Price Targets
Several firms have recently downgraded NUVL to 'hold'. On June 10, 2026, UBS, TD Cowen, Barclays, and Guggenheim all issued 'hold' ratings with a $124 price target. Earlier, on June 9, Wells Fargo, HC Wainwright & Co., Wedbush, and LifeSci Capital also downgraded the stock to 'hold', each setting a $124 target price. The consensus among analysts suggests a cautious outlook, with a mean target price of $124.
Bottom Line
UBS's downgrade to 'hold' reflects a cautious stance on NUVL, echoed by several other analysts. As these ratings are backward-looking, they provide insight into analysts' perspectives but do not necessarily predict future performance. Investors often watch such changes closely as part of their decision-making process.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.